Citius Oncology share price logo

Citius Oncology

NASDAQ: CTOR

$0.80

+0.02

(+2.85%)

Live

as on

Citius Oncology Stock Performance

as on September 4, 2026 at 1:28 am IST

  • $0.80
    $0.80
  • 52 Week's Low

    52 Week's High

    $0.49
    $2.25
    downward going graph

    38.60%

    Downside

    181.25%

    Upside

    downward going graph

Citius Oncology share price movements today

Previous Close
$0.78
Open
$0.80
Volume
300.0
Market Cap
$79.3M
Day's Low - High
$0.80 - $0.80
52 Week Low - High
$0.49 - $2.25

Citius Oncology Historical Returns

1 Month Return
+ 26.63 %
3 Month Return
-4.15 %
1 Year Return
-62.69 %
3 Year Return
0 %
5 Year Return
0 %

Citius Oncology Stock Fundamentals & Key Indicators

Check Citius Oncology market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$79.3M

EPS (TTM)

-0.47

Dividend Yield

0.00%

PE Ratio (TTM)

-1.76

Industry PE ratio

-7.783461538461538

PEG Ratio

0.04055804351340627

Return On Equity TTM

-99.47%

Citius Oncology Stock Valuation

Track how Citius Oncology P/E has moved over time to understand its valuation trends.

Citius Oncology in the last 4 years

  • Overview

  • Trends

Lowest (-189.69x)

September 30, 2022

Industry (-7.78x)

September 30, 2025

Today (-5.97x)

September 30, 2025

Highest (-4.70x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -5.97x

Citius Oncology vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Citius Oncology with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$79.3MNA-1.7680.07%NA
BUY$22.0B141.49%16.5886.14%NA
HOLD$19.0B9.91%-46.4434.83%2.87%
BUY$44.4BNA20.4714.55%121.78%
BUY$31.9B-63.08%12.4770.87%2.76%

Stock Returns calculator for Citius Oncology Stock including INR - Dollar returns

The Citius Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Citius Oncology investment value today

Current value as on today

₹42,694

Returns

-₹57,306

(-57.31%)

Returns from Citius Oncology Stock

-₹60,199 (-60.2%)

Dollar Impact

₹2,893 (+2.89%)

Analyst Recommendation on Citius Oncology Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Citius Oncology. Average target price of $4

Indian Investors' Interest in Citius Oncology Stock

Search interest for Citius Oncology Stock has increased by 63% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:63% versus previous 30 day period

Citius Oncology Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
3
1
Gross Profit
-
-
-
-
-
-
-
-
3
1
Operating Income
-4
-4
-4
-6
-6
-7
-4
-4
-5
-28
EBITDA
-4
-4
-4
-6
-6
-7
-4
-4
-4
-26
Interest Expense
-
-
-
-
-
-
0
0
0
0
Depreciation
-
-
-
-
-
-
-
-
0
-
Income Before Tax
-4
-4
-4
-6
-6
-7
-5
-4
-5
-26
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-4
-4
-4
-6
-6
-7
-5
-4
-5
-26
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
79.99%
80.27%

Citius Oncology Annual Profit & Loss

All numbers in Millions USD

Sep 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Income
-9
-12
-20
-23
EBITDA
-
-12
-20
-23
Interest Expense
-
-
-
0
Depreciation
9
-
-
-
Income Before Tax
-9
-12
-20
-23
Income Tax Expense
1
0
0
1
Net Income
-10
-12
-21
-24
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Citius Oncology Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
1
0
0
-22
-6
-7
-5
-4
-5
-26
Operating Cash Flow
0
0
0
0
-
-
-
-5
-7
-3
Investing Cash Flow
0
24
0
-29
-
-
-
-5
-4
0
Financing Cash Flow
0
-24
0
28
-
-
-
15
15
0
Change in Cash
0
0
0
0
0
-
-
3
3
-4

Citius Oncology Annual Cash Flow

All numbers in Millions USD

Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
0
2
-21
-24
Operating Cash Flow
0
0
0
-5
Investing Cash Flow
-67
-1
-5
-5
Financing Cash Flow
67
1
4
15
Change in Cash
0
0
0
3

Mutual Funds that own Citius Oncology Stock

Check out the Mutual Funds with significant holdings in Citius Oncology.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
0.575195%
534824
Fidelity Concord Street Trust
0.216031%
200869

Global Institutional Holdings in Citius Oncology

Funds
Holdings
Vanguard
0.59%

Insights on Citius Oncology

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, CTOR stock has moved up by 24.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 62.0% return, outperforming this stock by 122.5%

About Citius Oncology

Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.
OrganisationCitius Oncology
Headquarters11 Commerce Drive, Cranford, NJ, United States, 07016
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Leonard L. Mazur
E-voting on sharesClick here to vote

Key Management of Citius Oncology

Name

Title

Mr. Leonard L. Mazur

CEO, President & Executive Chairman

Mr. Myron Z. Holubiak

Secretary & Executive Vice Chairman

Dr. Myron S. Czuczman M.D.

Executive VP & Chief Medical Officer

FAQs

What is Citius Oncology share price today?

Citius Oncology share price today is $0.80 as on . Citius Oncology share today touched a day high of $0.80 and a low of $0.80.

What is the 52 week high and 52 week low for Citius Oncology share?

Citius Oncology share touched a 52 week high of $2.25 on and a 52 week low of $0.49 on . Citius Oncology stock price today i.e. is trending at $0.80,which is 64.44% down from its 52 week high and 62.87% up from its 52 week low.

What is Citius Oncology's market capitalisation today?

Citius Oncology market capitalisation is $0.00T as on .

How to invest in Citius Oncology Stock (CTOR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Citius Oncology on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Citius Oncology Shares that will get you 1.8750 shares as per Citius Oncology share price of $0.80 per share as on September 3, 2026 at 7:58 pm IST.

What is the minimum amount required to buy Citius Oncology Stock (CTOR) from India?

Indian investors can start investing in Citius Oncology (CTOR) shares with as little as ₹94.475 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Citius Oncology stock (as per the Rupee-Dollar exchange rate as on ). Based on Citius Oncology share’s latest price of $0.80 as on September 3, 2026 at 7:58 pm IST, you will get 12.5000 shares of Citius Oncology. Learn more about fractional shares .